M&A Deal Summary

Laurus Labs Acquires Richcore Lifesciences

On November 25, 2020, Laurus Labs acquired life science company Richcore Lifesciences from Eight Roads

Acquisition Highlights
  • This is Laurus Labs’ 1st transaction in the Life Science sector.
  • This is Laurus Labs’ 1st transaction in India.

M&A Deal Summary

Date 2020-11-25
Target Richcore Lifesciences
Sector Life Science
Buyer(s) Laurus Labs
Sellers(s) Eight Roads
Deal Type Add-on Acquisition

Target

Richcore Lifesciences

Bangalore, India
Richcore Lifesciences is an innovation-driven company focused on development and manufacture of industrial enzymes that have global relevance. Richcore Lifesciences was founded in 2005 and is based in Bengaluru, India.

Search 214,356 Deals Now

SEARCH BY

  • Buyer Type (PE or Strategic)
  • Deal Size ($10M to $10B+)
  • Sector (60 Sectors)
  • Deal Type
  • Geography
  • & More

Try Free

Buyer(S) 1

Buyer

Laurus Labs

Hyderabad, India

Category Company
Founded 2005
Sector Life Science
Employees6,167
Revenue 55.1B INR (2025)
DESCRIPTION

Laurus Labs develops and manufacturers active pharmaceutical ingredients (API), with a focus on anti-retroviral (ARV) and oncology products. Laurus Labs was founded in 2005 and is based in Hyderabad, Telangana.


DEAL STATS #
Overall 1 of 1
Sector: Life Science M&A 1 of 1
Type: Add-on Acquisition M&A Deals 1 of 1
Country: India M&A 1 of 1
Year: 2020 M&A 1 of 1
PREVIOUS DEAL
DATE TARGET DEAL TYPE VALUE
2018-10-23 Laurus Labs Private - HBV ANDA

Hyderabad, India

Laurus Labs Private Ltd. - HBV ANDA is a drug, tenofovir disoproxil fumarate (TDF), is indicated for the treatment of hepatitis B virus (HBV). There are more than 90 million chronic carriers of hepatitis B in China which accounts for roughly one-third of all HBV chronic carriers in the world, with TDF currently as the first line therapy.

Sell -

Seller(S) 1

SELLER

Eight Roads

Investor Investor Investor Investor Investor


Category Private Equity Firm
Founded 1969
PE ASSETS 11.0B USD
Size Mega
Type Sector Focused
DESCRIPTION

Eight Roads is a private investment firm focused on a variety of investment opportunities across the US, Europe, and Asia. The Firm is divided into several investment strategies including venture, principal investing, and real estate. Within the principal investments group, Eight Roads backs established growth businesses with long-term capital. Eight Roads does not have any sector preferences, but has experience in fintech, business services, and healthcare. Eight Roads is based in London.


DEAL STATS #
Overall 63 of 124
Sector: Life Science M&A 37 of 51
Type: Add-on Acquisition M&A Deals 28 of 59
Country: India M&A 4 of 12
Year: 2020 M&A 12 of 17
PREVIOUS DEAL
DATE TARGET DEAL TYPE VALUE
2020-11-17 Tibber

Forde, Norway

Tibber is a smart digital energy provider through its app that replaces traditional utilities with a digital energy deal and technology for smarter consumption of energy. The company's vision is to make sustainable energy consumption simple and affordable for all households, and its mission is to reduce the residential energy consumption for European households by 20%. Tibber was founded in 2016 and is based in Forde, Norway.

Buy -
FOLLOWING DEAL
DATE TARGET DEAL TYPE VALUE
2020-11-27 Optegra

London, United Kingdom

Optegra is an eye healthcare provider treating A-Z eye conditions that is supported by dedicated optometrists, healthcare technicians and consultants who provide a wide range of procedures including lens replacement (Clarivu), laser eye surgery, cataract removal, glaucoma, and AMD. Optegra was founded in 2007 and is based in London, United Kingdom.

Sell -